TABLE 3

LPS-induced pulmonary neutrophilia

LPS was instilled into the nares of BALB/c mice, followed 30 min later by treatment with aerosolized vehicle (water/tyloxapol), aerosolized TG100-115, or systemic steroid. Four hours after LPS administration, BALF was collected and analyzed for neutrophil counts (presented as percentage of total cells present) and TNFα levels. Data are presented as means ± S.E.M. Study 1, n = 4, all groups differ from one another by P < 0.01 for both measures. Study 2, n = 5 to 6, all groups differ from one another by P < 0.01 for both measures except for the 0.04 and 0.4% TG100-115 groups and the 0.004% TG100-115 and non-LPS control groups.


Study

LPS

Treatment

Neutrophils

TNFα
% Total Cells pg/ml
Study 1 No Aerosolized vehicle 4 ± 3 22 ± 7
Yes Aerosolized vehicle 64 ± 6 1836 ± 178
Yes Aerosolized TG100-115 (0.4% formulation) 39 ± 5 952 ± 182
Yes Dexamethasone (0.3 mg/kg i.p.) 22 ± 3 346 ± 68
Study 2 No Aerosolized vehicle 16 ± 4 256 ± 59
Yes Aerosolized vehicle 53 ± 4 1784 ± 240
Yes Aerosolized TG100-115 (0.004% formulation) 18 ± 5 738 ± 227
Yes Aerosolized TG100-115 (0.04% formulation) 36 ± 3 1077 ± 109

Yes
Aerosolized TG100-115 (0.4% formulation)
33 ± 1
1267 ± 115